Edap TMS SA (EDAP)
6.71
-0.18
(-2.61%)
USD |
NASDAQ |
May 17, 16:00
6.79
+0.08
(+1.19%)
After-Hours: 20:00
Edap TMS Free Cash Flow: -20.54M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -20.54M |
| September 30, 2023 | -22.46M |
| June 30, 2023 | -18.07M |
| March 31, 2023 | -10.71M |
| December 31, 2022 | -5.636M |
| Date | Value |
|---|---|
| September 30, 2022 | 4.236M |
| June 30, 2022 | 3.257M |
| March 31, 2022 | 2.327M |
| December 31, 2021 | 3.312M |
| September 30, 2021 | 0.8892M |
Free Cash Flow Range, Past 5 Years
-22.46M
Minimum
Sep 2023
4.236M
Maximum
Sep 2022
-6.340M
Average
-2.373M
Median
Free Cash Flow Benchmarks
| Biophytis SA | -14.21M |
| Cellectis SA | -25.82M |
| DBV Technologies SA | -95.40M |
| Genfit SA | -- |
| Biodexa Pharmaceuticals Plc | -8.842M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.726M |
| Cash from Investing (Quarterly) | -0.8921M |
| Cash from Financing (Quarterly) | 0.3802M |
| Free Cash Flow Per Share (Quarterly) | -0.1502 |
| Free Cash Flow to Equity (Quarterly) | -7.935M |
| Free Cash Flow to Firm (Quarterly) | -5.566M |
| Free Cash Flow Yield | -8.27% |